CAREY STEPHEN P. 4

What Happened
Stephen P. Carey, SVP & Chief Financial Officer of ANI Pharmaceuticals (ANIP), had a total of 5,277 shares disposed via tax withholding following the vesting of restricted stock. On Feb 12, 2026, 2,829 shares were withheld at $76.70 each (value $216,984). On Feb 14, 2026, 2,448 shares were withheld at $77.36 each (value $189,377). Combined, the withheld shares were worth about $406,361. These were tax-withholding dispositions tied to RSU vesting (routine administrative transactions), not open-market sales for investment purposes.

Key Details

• Transaction dates and prices:
  • 2026-02-12: 2,829 shares withheld @ $76.70 = $216,984 (footnote F1)
  • 2026-02-14: 2,448 shares withheld @ $77.36 = $189,377 (footnote F2)
• Total shares withheld: 5,277; total value ≈ $406,361.
• Shares owned after transaction: Not specified in the filed Form 4.
• Footnotes:
  • F1: Withheld in connection with vesting of 6,202 restricted shares (grant previously reported 2025-02-18); exempt under Rule 16(b)-3.
  • F2: Withheld in connection with vesting of 5,368 restricted shares (grant previously reported 2024-02-16); exempt under Rule 16(b)-3.
• Filing: Report filed Feb 17, 2026; the Form 4 shows these withholding transactions and does not carry a late-filing flag.

Context
These transactions represent shares withheld to satisfy tax withholding obligations upon RSU vesting (a common administrative step), not discretionary open-market selling or a buy signal. Because the disposals are tax withholdings and are exempt under Rule 16(b)-3, they generally do not reflect insider sentiment about the company’s stock price.